
Press 2017
Dec 22, 2017 |
Biostage Announces Reverse Stock Split Effective December 22, 2017
|
Dec 14, 2017 |
Biostage Announces Binding Agreement For $4.0 Million Private Placement
|
Oct 12, 2017 |
Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives
|
Oct 06, 2017 |
Biostage to Move to OTCQB Marketplace
|
Oct 02, 2017 |
Biostage to Present at the 2017 Cell & Gene Meeting on the Mesa
|
Aug 14, 2017 |
Biostage Reports 2017 Second Quarter Financial Results:
|
Aug 07, 2017 |
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
|
Aug 04, 2017 |
Biostage to Host Conference Call to Discuss Second Quarter 2017 Financial Results and Business Update
|
Jul 10, 2017 |
Biostage Granted Continued Listing on Nasdaq
|
Jun 27, 2017 |
Biostage Announces Agreement to Conduct $3.1 Million Private Placement at Market
|
Jun 19, 2017 |
Biostage Announces Positive Preclinical Data of Cellspan™ Esophageal Implant Presented at the International Society for Stem Cell Research 2017 Annual Meeting
|
Jun 14, 2017 |
Biostage to Present at the 2017 Marcum MicroCap Conference
|
May 23, 2017 |
Biostage to Present at the Cell and Gene Exchange 2017
|
May 22, 2017 |
Biostage Announces Receipt of Nasdaq Listing Determination
|
May 11, 2017 |
Biostage Reports 2017 First Quarter Financial Results and Provides Business Update
|
May 05, 2017 |
Biostage to Host 2017 First Quarter Update Conference Call
|
May 01, 2017 |
Biostage to Present at the American Association for Thoracic Surgery Centennial Meeting
|
Apr 26, 2017 |
Biostage to Participate at the Alliance for Regenerative Medicine's 5th Annual Cell & Gene Therapy Investor Day
|
Apr 18, 2017 |
Biostage Appoints Stephen F. Badylak DVM, PhD, MD, as Co-Chairman of Scientific Advisory Board
|
Apr 06, 2017 |
Biostage Presents Positive Preclincal Data of Cellspan Esophageal Implant at Society For Biomaterials 2017 Annual Meeting and Exposition
|
Mar 28, 2017 |
Biostage to Participate at the MassBio 2017 Annual Meeting
|
Mar 16, 2017 |
Biostage Promotes Saverio La Francesca, M.D. to President
|
Mar 09, 2017 |
Biostage Reports 2016 Financial Results and Provides Business Update
|
Mar 02, 2017 |
Biostage to Host Fiscal Year 2016 Update Conference Call
|
Feb 16, 2017 |
Biostage Announces Closing of $8.0 Million Public Offering
|
Feb 10, 2017 |
Biostage Announces $8.0 Million Public Offering
|
Jan 06, 2017 |
Biostage to Present at Biotech Showcase™ 2017
|